GO:0106435 carboxylesterase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106435 carboxylesterase activity is a molecular function defined as the catalysis of the reaction: a carboxylic ester + H2O = a carboxylate + an alcohol + H+.
• Carboxylesterases are serine hydrolases that hydrolyze ester bonds in xenobiotics, drugs, and endogenous lipids, and are inhibited by organophosphates and other compounds.
• The human carboxylesterase family includes CES1, CES2, and CES3, which show tissue-specific expression and substrate selectivity.
• Genetic variants in carboxylesterase genes affect drug metabolism, including responses to irinotecan, oseltamivir, and clopidogrel.
• Activity-based probes enable selective detection of CES1 and CES2 activity in live cells and cancer models.
• Carboxylesterase activity is implicated in inflammation, cancer, and metabolic disorders, making it a target for inhibitor and prodrug design.
Description
Carboxylesterase activity (GO:0106435) is a fundamental molecular function that catalyzes the hydrolysis of carboxylic esters into a carboxylate, an alcohol, and a proton. This reaction is essential for the metabolism of numerous endogenous and exogenous compounds, including drugs, environmental toxicants, and lipids. The term encompasses a diverse group of enzymes found across species, from bacteria to humans, and is characterized by a serine hydrolase catalytic mechanism. In biomedical research, carboxylesterase activity is of major interest because it influences drug pharmacokinetics, detoxification pathways, and lipid signaling. For example, human carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2) are key enzymes in the activation of prodrugs such as irinotecan and the hydrolysis of cocaine and heroin. Moreover, altered carboxylesterase activity has been linked to cancer, inflammation, and metabolic diseases. Understanding the regulation and substrate specificity of these enzymes is therefore critical for drug development and precision medicine. This article provides a comprehensive overview of GO:0106435, covering its definition, biological roles, key genes, disease associations, and research methodologies, with a focus on CRISPR-based models and EDITGENE services.
carboxylesterase activity At A Glance
| GO ID | GO:0106435 |
|---|---|
| GO term | carboxylesterase activity |
| Ontology | molecular_function |
| Synonym | ali-esterase activity, alpha-carboxylesterase activity, B-esterase activity, cocaine esterase, nonspecific carboxylesterase activity, procaine esterase, serine esterase activity, triacetin esterase, vitamin A esterase |
| Definition | Catalysis of the reaction: a carboxylic ester + H2O = a carboxylate + an alcohol + H+ |
| Major function | Hydrolysis of ester bonds in xenobiotics, drugs, and endogenous lipids |
| EC number | 3.1.1.1 (carboxylesterase) |
| Catalytic mechanism | Serine hydrolase with catalytic triad |
| Inhibitors | Organophosphates, carbamates, and specific inhibitors |
What Is GO:0106435?
According to the Gene Ontology, GO:0106435 carboxylesterase activity is defined as the catalysis of the reaction: a carboxylic ester + H2O = a carboxylate + an alcohol + H+. This activity is mediated by enzymes known as carboxylesterases, which belong to the serine hydrolase superfamily and typically contain a catalytic triad (Ser-His-Glu/Asp). The term is synonymous with ali-esterase activity, alpha-carboxylesterase activity, B-esterase activity, cocaine esterase, nonspecific carboxylesterase activity, procaine esterase, serine esterase activity, triacetin esterase, and vitamin A esterase. Carboxylesterases are found in many organisms and tissues, where they play roles in detoxification, lipid metabolism, and drug activation.
Why Is carboxylesterase activity Important in Cell Biology?
Carboxylesterase activity is crucial for the metabolism of a wide range of compounds, including therapeutic drugs, environmental toxins, and endogenous signaling molecules. It affects drug efficacy and toxicity, as seen with irinotecan and oseltamivir. Additionally, carboxylesterases regulate lipid metabolism and inflammation, and their dysregulation is associated with cancer and metabolic disorders. Therefore, studying this activity is essential for pharmacology, toxicology, and disease research.
• Drug metabolism: CES1 and CES2 hydrolyze ester-containing drugs, influencing their pharmacokinetics and pharmacodynamics.
• Prodrug activation: Carboxylesterases convert prodrugs like irinotecan to active metabolites.
• Detoxification: They hydrolyze environmental toxicants such as pyrethroids.
• Lipid signaling: CES2g regulates 2-arachidonoylglycerol levels, affecting inflammation.
• Cancer: Altered carboxylesterase activity is observed in various cancers and can be targeted for imaging.
• Inflammation: Lipopolysaccharide suppresses carboxylesterase 2g activity, linking it to inflammatory pathways.
• Obesity: Regional differences in carboxylesterase activity in adipose tissue suggest a role in fat metabolism.
• Biotechnology: Carboxylesterases with promiscuous acyltransferase activity are useful for glycoside modification.
• Pest resistance: Mutations in carboxylesterases improve insecticide detoxification in pests.
• Therapeutic targeting: Inhibitors of carboxylesterases are being developed for clinical applications.
Molecular Mechanism of carboxylesterase activity
Substrate Binding and Catalytic Triad
In simple terms: The enzyme grabs the ester molecule and uses a trio of amino acids to break it apart.
Carboxylesterases typically contain a catalytic triad consisting of serine, histidine, and glutamate or aspartate. The serine residue acts as a nucleophile, attacking the carbonyl carbon of the ester bond. This forms an acyl-enzyme intermediate, which is subsequently hydrolyzed by water to release the carboxylate and alcohol products. The substrate specificity varies among family members; for example, CES1 prefers substrates with a small alcohol group and a large acyl group, while CES2 favors the opposite.
Cofactors and Cofactor Requirements
In simple terms: These enzymes do not need extra helper molecules; they work on their own.
Carboxylesterases do not require cofactors such as NAD+ or FAD for their hydrolytic activity. They are serine hydrolases that rely solely on the catalytic triad and water. However, some family VIII carboxylesterases may exhibit acyltransferase activity, transferring acyl groups to other molecules, which can be influenced by the presence of acceptor substrates.
Regulation of Enzyme Activity
In simple terms: The activity of these enzymes can be turned up or down by other molecules or genetic changes.
Carboxylesterase activity can be regulated at multiple levels. Genetic polymorphisms in CES1 and CES2 affect enzyme expression and function, leading to interindividual variability in drug metabolism. Additionally, inflammatory stimuli such as lipopolysaccharide can suppress carboxylesterase 2g activity, reducing 2-arachidonoylglycerol hydrolysis and potentially modulating inflammation. Inhibitors, including organophosphates and specific small molecules, can also block activity.
Substrate Specificity and Tissue Distribution
In simple terms: Different carboxylesterases are found in different tissues and prefer different targets.
Human CES1 is predominantly expressed in the liver, while CES2 is found in the intestine and liver. This tissue-specific distribution influences drug metabolism; for example, CES2 is responsible for activating irinotecan in the intestine. In adipose tissue, carboxylesterase activity differs between subcutaneous and omental depots, suggesting depot-specific roles in lipid metabolism. Insect carboxylesterases, such as those in Helicoverpa armigera, can be mutated to enhance insecticide hydrolysis.
Detection and Activity Probes
In simple terms: Scientists use special chemical probes that light up when the enzyme is active.
Activity-based probes have been developed to selectively detect carboxylesterase activity in live cells. For instance, a chemiluminescent probe enables selective detection of CES2 activity in cancer cells, and a carbonate-based fluorescent probe allows monitoring of CES1 activity variations. These tools are valuable for studying enzyme function in physiological and pathological contexts.
Key Genes Involved in GO:0106435 carboxylesterase activity
The following genes encode enzymes with carboxylesterase activity or are closely related to its function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CES1 | Hydrolyzes esters, activates prodrugs, metabolizes drugs | Drug metabolism, prodrug activation, inhibitor development |
| CES2 | Hydrolyzes esters, activates irinotecan, metabolizes cocaine | Cancer therapy, drug response, activity probes |
| CES3 | Carboxylesterase with broad substrate specificity | Lipid metabolism, drug metabolism |
| CES2G | Hydrolyzes 2-arachidonoylglycerol, regulates inflammation | Inflammation, endocannabinoid signaling |
| CES1A1 | Major liver carboxylesterase | Drug metabolism, genetic variation |
| CES1A2 | Variant of CES1 with altered activity | Pharmacogenomics |
| CES2A1 | Intestinal carboxylesterase | Drug absorption, prodrug activation |
| CES5A | Carboxylesterase-like enzyme | Unknown, potential role in metabolism |
| CES4A | Carboxylesterase family member | Unknown, potential role in lipid metabolism |
| CES6 | Carboxylesterase family member | Unknown |
| CES7 | Carboxylesterase family member | Unknown |
| CES8 | Carboxylesterase family member | Unknown |
| CES1C | Mouse carboxylesterase | Model for drug metabolism |
| CES2C | Mouse carboxylesterase | Model for lipid metabolism |
| CES001C | Insect carboxylesterase | Insecticide resistance |
| AChE | Acetylcholinesterase, related serine hydrolase | Neurotransmission, inhibitor studies |
| BChE | Butyrylcholinesterase, related serine hydrolase | Drug metabolism, inhibitor studies |
| PON1 | Paraoxonase, related esterase | Lipid metabolism, detoxification |
How Is carboxylesterase activity Regulated?
Carboxylesterase activity is regulated by genetic polymorphisms, transcriptional control, and post-translational modifications. In humans, single nucleotide polymorphisms in CES1 and CES2 can lead to reduced or enhanced enzyme activity, affecting drug metabolism. Inflammatory mediators such as lipopolysaccharide can suppress CES2g activity, thereby increasing 2-arachidonoylglycerol levels and modulating inflammation. Additionally, enzyme activity can be inhibited by organophosphates and other chemicals, which is relevant for toxicology and drug interactions.
carboxylesterase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CES2 | Colorectal cancer, irinotecan response | Knockout cell lines, xenograft models |
| CES1 | Drug metabolism variability, clopidogrel resistance | Point mutation knock-in mice |
| CES2G | Inflammation, endocannabinoid signaling | Knockout mice, LPS challenge |
| CES1C | Obesity, lipid metabolism | Overexpression in adipocytes |
| CES001C | Insecticide resistance | Point mutation in insect cells |
Cancer
Carboxylesterase activity is implicated in cancer biology and therapy. CES2 activates irinotecan, a prodrug used in colorectal cancer, and its activity levels can predict treatment response. Activity-based probes have been used to detect CES2 activity in cancer cells, highlighting its potential as a biomarker. Furthermore, carboxylesterase inhibitors are being explored as anticancer agents.
Inflammation
Carboxylesterase 2g hydrolyzes 2-arachidonoylglycerol, an endocannabinoid with anti-inflammatory effects. Lipopolysaccharide suppresses CES2g activity, leading to reduced 2-arachidonoylglycerol hydrolysis and potentially modulating inflammatory responses. This links carboxylesterase activity to the regulation of inflammation.
Metabolic Disorders
Regional differences in carboxylesterase activity between subcutaneous and omental adipose tissue suggest a role in obesity and metabolic syndrome. Additionally, carboxylesterases are involved in lipid metabolism, and their dysregulation may contribute to metabolic disorders.
Drug Metabolism and Pharmacogenomics
Genetic variations in carboxylesterases affect the metabolism of drugs such as clopidogrel, oseltamivir, and irinotecan, leading to interindividual differences in drug efficacy and toxicity. This has important clinical implications for personalized medicine.
From carboxylesterase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CES2 knockout affect irinotecan sensitivity? | CES2 knockout cancer cell lines |
| What is the effect of CES1 polymorphism on drug metabolism? | CES1 point mutation knock-in hepatocytes |
| Can CES2 activity be visualized in live cells? | CES2 knock-in with fluorescent tag |
| Does CES2g overexpression reduce inflammation? | CES2g overexpression in macrophages |
| What is the role of CES1 in lipid metabolism? | CES1 knockout mouse models |
| Can carboxylesterase inhibitors be tested for specificity? | CRISPR knockout of CES1 and CES2 in cell lines |
How to Study the carboxylesterase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Activity-based probes | Active enzyme levels | Live-cell imaging, cancer detection |
| Chromogenic assays | Hydrolytic activity | Inhibitor screening, enzyme kinetics |
| CRISPR knockout | Gene function | Drug metabolism studies |
| RNA-seq | Gene expression | Tissue-specific expression profiling |
| Proteomics | Protein abundance | Quantification of enzyme levels |
| Site-directed mutagenesis | Catalytic residues | Mechanistic studies |
| Metagenomic library screening | Novel carboxylesterases | Biocatalyst discovery |
Activity-Based Probes
Activity-based probes are chemical tools that covalently label active carboxylesterases, allowing detection and quantification of enzyme activity in live cells and tissues. For example, a chemiluminescent probe selectively detects CES2 activity in cancer cells, and a fluorescent probe monitors CES1 activity variations. These probes are valuable for high-throughput screening and imaging.
Enzymatic Assays
Traditional enzymatic assays use chromogenic or fluorogenic substrates such as p-nitrophenyl esters to measure carboxylesterase activity in cell lysates or purified enzyme preparations. These assays are simple and can be adapted for inhibitor screening.
Genetic Knockout and Knock-in Models
CRISPR/Cas9-mediated knockout of carboxylesterase genes in cell lines and animal models allows researchers to study the specific contributions of each enzyme to drug metabolism and disease. Knock-in of human variants can model pharmacogenetic differences.
Proteomic and Transcriptomic Profiling
RNA-seq and proteomics can quantify carboxylesterase expression levels across tissues and conditions, revealing regulatory mechanisms and splice variants. These methods complement activity assays to provide a comprehensive view.
How CRISPR Can Be Used to Study GO:0106435 carboxylesterase activity
Knockout
CRISPR/Cas9 knockout of CES1 or CES2 in cell lines such as HepG2 or HEK293 can abolish specific carboxylesterase activity, enabling researchers to attribute drug metabolism or lipid hydrolysis to individual enzymes. For example, CES2 knockout cells show reduced irinotecan activation.
Point Mutation
Introducing point mutations in the catalytic triad (e.g., Ser to Ala) of carboxylesterases via CRISPR can create catalytically dead enzymes, serving as negative controls. Additionally, modeling human polymorphisms such as CES1 G143E can reveal altered drug metabolism.
Knock-in
Knock-in of tagged carboxylesterases (e.g., GFP or HA) allows visualization and immunoprecipitation of the enzyme in its native context. This is useful for studying subcellular localization and interacting partners.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of carboxylesterases can increase enzyme activity, useful for prodrug activation studies and for testing inhibitor efficacy in a high-activity background.
How EDITGENE Supports carboxylesterase activity Research
Researchers studying carboxylesterase activity-related genes often need to determine whether a candidate gene is causally involved in drug metabolism, lipid signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic modifications in cell models, from knockout to knock-in, tailored to your research questions.
Contact EDITGENE today to design your custom CRISPR model for carboxylesterase activity research.
Frequently Asked Questions About carboxylesterase activity
What is carboxylesterase activity?
Carboxylesterase activity (GO:0106435) is a molecular function that catalyzes the hydrolysis of carboxylic esters into a carboxylate, an alcohol, and a proton. It is mediated by enzymes called carboxylesterases.
What genes are involved in carboxylesterase activity?
Key human genes include CES1, CES2, and CES3, which encode enzymes with carboxylesterase activity. Other family members exist but are less characterized.
What diseases are associated with carboxylesterase activity?
Altered carboxylesterase activity is linked to cancer (e.g., irinotecan response), inflammation, obesity, and variable drug metabolism.
How is carboxylesterase activity measured?
It can be measured using activity-based probes, chromogenic substrates, or fluorescent probes that detect hydrolysis in live cells or lysates.
What is the role of CES1 in drug metabolism?
CES1 hydrolyzes ester-containing drugs such as clopidogrel and oseltamivir, affecting their efficacy and toxicity.
What is the role of CES2 in cancer?
CES2 activates irinotecan, a prodrug used in colorectal cancer, and its activity levels can predict treatment response.
How can CRISPR be used to study carboxylesterase activity?
CRISPR knockout, knock-in, and point mutation models allow researchers to dissect the specific roles of carboxylesterase genes in drug metabolism and disease.
What are carboxylesterase inhibitors?
Carboxylesterase inhibitors are compounds that block enzyme activity, including organophosphates and specific small molecules. They are studied for therapeutic applications.
Is carboxylesterase activity involved in inflammation?
Yes, carboxylesterase 2g hydrolyzes 2-arachidonoylglycerol, and its suppression by lipopolysaccharide links it to inflammation regulation.
What model systems are used to study carboxylesterase activity?
Common models include human cell lines (e.g., HepG2, HEK293), mouse models, and insect cells for pesticide research. CRISPR-edited cells are increasingly used.
Conclusion
Carboxylesterase activity (GO:0106435) is a critical molecular function with broad implications in drug metabolism, detoxification, lipid signaling, and disease. Understanding its mechanisms and regulation can inform drug development and personalized medicine. EDITGENE provides advanced CRISPR tools to study carboxylesterase genes, enabling precise genetic models for research and therapeutic discovery.
References
- 1. Zou LW et al.. 2018. Carboxylesterase Inhibitors: An Update.. Curr Med Chem 25(14):1627-1649 PMID: 29210644
- 2. Ozsan C et al.. 2022. Selective detection of carboxylesterase 2 activity in cancer cells using an activity-based chemiluminescent probe.. Chem Commun (Camb) 58(78):10929-10932 PMID: 36065979
- 3. Singh A et al.. 2022. Carbonate-Based Fluorescent Chemical Tool for Uncovering Carboxylesterase 1 (CES1) Activity Variations in Live Cells.. Chembiochem 23(12):e202200069 PMID: 35255177
- 4. Zhang Y et al.. 2023. Identification and Characterization of a Novel Carboxylesterase Belonging to Family VIII with Promiscuous Acyltransferase Activity Toward Cyanidin-3-O-Glucoside from a Soil Metagenomic Library.. Appl Biochem Biotechnol 195(4):2432-2450 PMID: 34255285
- 5. Taniguchi A et al.. 1985. Regional differences in carboxylesterase activity between human subcutaneous and omental adipose tissue.. Life Sci 36(15):1465-71 PMID: 3982221
- 6. Xu JJ et al.. 2021. Two single mutations in carboxylesterase 001C improve fenvalerate hydrolase activity in Helicoverpa armigera.. Pestic Biochem Physiol 179:104969 PMID: 34802519
- 7. Szafran B et al.. 2015. Lipopolysaccharide suppresses carboxylesterase 2g activity and 2-arachidonoylglycerol hydrolysis: A possible mechanism to regulate inflammation.. Prostaglandins Other Lipid Mediat 121(Pt B):199-206 PMID: 26403860
- 8. Chen F et al.. 2018. Clinical implications of genetic variation in carboxylesterase drug metabolism.. Expert Opin Drug Metab Toxicol 14(2):131-142 PMID: 29264996
